Russell M Medford's Net Worth

$5.71 Million

Estimate Recalculated Sep 8, 2024 07:27PM EST

Who is Russell M Medford?

Russell M Medford has an estimated net worth of $5.71 Million. This is based on reported shares across multiple companies, which include CESCA THERAPEUTICS INC., ATHEROGENICS INC, and INHIBITEX, INC..

SEC CIK

Russell M Medford's CIK is 0001228959

Past Insider Trading and Trends

2006 was Russell M Medford's most active year for acquiring shares with 6 total transactions. Russell M Medford's most active month to acquire stocks was the month of January. 2012 was Russell M Medford's most active year for disposing of shares, totalling 9 transactions. Russell M Medford's most active month to dispose stocks was the month of January. 2006 saw Russell M Medford paying a total of $161,125.14 for 322,493 shares, this is the most they've acquired in one year. In 2005 Russell M Medford cashed out on 375,000 shares for a total of $4,754,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CESCA THERAPEUTICS INC. (THMO) Snapshot price: $0.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Sep 16
Form 4
—
0
—
—
0
Apr 16
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
May 10
Form 3
—
0
—
—
0
No matching records found

ATHEROGENICS INC No price found

President & CEO

Russell M Medford owns 397,141 units of Common stock.acquired a total of 147,500 shares in ATHEROGENICS INC at a cost of $24,250.00, Russell also disposed a total of 325,000 shares of ATHEROGENICS INC equalling to $5,891,000.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 31
Form 4
+2.58%
10K
$0.30
$3,000.00
397.14K
Aug 1
Form 4
—
0
—
—
0
Jun 19
Form 4
+2.65%
10K
$0.30
$3,000.00
387.14K
Jun 5
Form 4
—
0
—
—
0
Dec 29
Form 4
+0.67%
2.5K
$0.30
$750.00
377.14K
Apr 12
Form 4
—
0
—
—
0
Feb 21
Form 4
-28.59%
-150.00K
$20.02
-$3,003,000.00
374.64K
Dec 28
Form 4
+5.00%
25K
$0.30
$7,500.00
524.64K
Apr 29
Form 4
—
0
$8.81
-$1,741,000.00
499.64K
Feb 24
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Dec 31
Form 4
-13.05%
-75.00K
$15.16
-$1,137,000.00
499.64K
Nov 18
No matching records found

INHIBITEX, INC. No price found

Investor

Russell M Medford owns 52,493 units of Restricted Stock and 49,497 units of Common Stock. From 2004 to 2012 Russell M Medford acquired a total of 64,195 shares in INHIBITEX, INC. at a cost of $199,789.90, Russell also disposed a total of 18,448 shares of INHIBITEX, INC. equalling to $44,388.18.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Feb 1
Form 4
+30.96%
11.7K
$9.00
$105,339.76
49.5K
Jan 18
Form 4
-3.20%
-1.25K
$14.50
-$18,125.00
37.8K
Scheduled
Dec 12
Form 4
-3.20%
-1.25K
$9.25
-$11,562.50
37.8K
Scheduled
Nov 14
Form 4
-1.63%
-1.25K
$4.00
-$5,000.00
75.59K
Scheduled
Oct 31 - Nov 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Nov 4
Form 4
—
0
—
—
0
Feb 2
Form 4
-28.00%
-14.70K
$0.66
-$9,700.68
37.8K
Jul 3
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
+424.93%
42.49K
$1.77
$75,000.14
52.49K
Jul 3
Form 4
∞
10K
$1.95
$19,450.00
10K
May 18
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 3
—
0
—
—
0
No matching records found